Glenmede Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $63.6M | Buy |
|
|||||
|
2024
Q4 | $58.3M | Buy |
|
|||||
|
2024
Q3 | $48.8M | Sell |
|
|||||
|
2024
Q2 | $51.5M | Sell |
|
|||||
|
2024
Q1 | $74.4M | Sell |
|
|||||
|
2023
Q4 | $72.3M | Buy |
|
|||||
|
2023
Q3 | $72.2M | Sell |
|
|||||
|
2023
Q2 | $111M | Sell |
|
|||||
|
2023
Q1 | $111M | Buy |
|
|||||
|
2022
Q4 | $115M | Sell |
|
|||||
|
2022
Q3 | $115M | Buy |
|
|||||
|
2022
Q2 | $123M | Buy |
|
|||||
|
2022
Q1 | $105M | Sell |
|
|||||
|
2021
Q4 | $89.7M | Sell |
|
|||||
|
2021
Q3 | $88.4M | Sell |
|
|||||
|
2021
Q2 | $101M | Sell |
|
|||||
|
2021
Q1 | $99.6M | Sell |
|
|||||
|
2020
Q4 | $102M | Sell |
|
|||||
|
2020
Q3 | $99.6M | Sell |
|
|||||
|
2020
Q2 | $97.7M | Sell |
|
|||||
|
2020
Q1 | $224M | Hold |
|
|||||
|
2019
Q4 | $224M | Buy |
|
|||||
|
2019
Q3 | $97.7K | Buy |
|
|||||
|
2019
Q2 | $77.5K | Buy |
|
|||||
|
2019
Q1 | $68.3K | Buy |
|
|||||
|
2018
Q4 | $34.1K | Buy |
|
|||||
|
2018
Q3 | $34.9M | Buy |
|
|||||
|
2018
Q2 | $25.7M | Buy |
|
|||||
|
2018
Q1 | $27.3M | Hold |
|
|||||
|
2017
Q4 | $27.3M | Buy |
|
|||||
|
2017
Q3 | $25.6M | Buy |
|
|||||
|
2017
Q2 | $18.9M | Hold |
|
|||||
|
2017
Q1 | $18.9M | Sell |
|
|||||
|
2016
Q4 | $20.6M | Sell |
|
|||||
|
2016
Q3 | $19.5M | Sell |
|
|||||
|
2016
Q2 | $27.2M | Sell |
|
|||||
|
2016
Q1 | $23.6M | Sell |
|
|||||
|
2015
Q4 | $27.1M | Buy |
|
|||||
|
2015
Q3 | $23M | Buy |
|
|||||
|
2015
Q2 | $25.8M | Sell |
|
|||||
|
2015
Q1 | $27.2M | Buy |
|
|||||
|
2014
Q4 | $24.6M | Buy |
|
|||||
|
2014
Q3 | $20.8M | Sell |
|
|||||
|
2014
Q2 | $21.2M | Buy |
|
|||||
|
2014
Q1 | $22.7M | Sell |
|
|||||
|
2013
Q4 | $23.9M | Buy |
|
|||||
|
2013
Q3 | $17.8M | Sell |
|
|||||
|
2013
Q2 | $17.3M | Buy |
|